WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003002102) SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2003/002102 International Application No.: PCT/AU2002/000865
Publication Date: 09.01.2003 International Filing Date: 01.07.2002
Chapter 2 Demand Filed: 07.01.2003
IPC:
A61K 9/00 (2006.01) ,A61K 31/365 (2006.01) ,A61K 38/00 (2006.01) ,A61K 38/18 (2006.01) ,A61K 38/19 (2006.01) ,A61K 38/22 (2006.01) ,A61K 38/43 (2006.01)
Applicants: MARTINOD, Serge, R.[US/US]; US (UsOnly)
BRANDON, Malcolm[AU/AU]; AU (UsOnly)
SMART DRUG SYSTEMS INC[US/US]; 181 South Broad Street Suite 102 Pawcatuck, CT 06379, US (AllExceptUS)
Inventors: MARTINOD, Serge, R.; US
BRANDON, Malcolm; AU
Agent: FREEHILLS CARTER SMITH BEADLE; Level 43 101 Collins Street Melbourne, Victoria 3000, AU
Priority Data:
PR 602529.06.2001AU
Title (EN) SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
(FR) COMPOSITION PHARMACEUTIQUE A LIBERATION PROLONGEE
Abstract:
(EN) A sustained release apparatus including a plurality of sustained release mini-implants or pellets; each mini-implant including a sustained release support material; and a pharmaceutically active composition carried in or on the sustained release support material; the pharmaceutically active composition including at least one pharmaceutically active component; and a carrier therefor; each implant being of insufficient size and/or payload individually to provide a predetermined desired threshold blood level of pharmaceutical active for treatment of a selected indication.
(FR) L'invention concerne un appareil de libération prolongée comprenant plusieurs mini-implants ou comprimés de libération prolongée. Chaque mini-implant comprend un matériau support de libération prolongée, et une composition active au niveau pharmaceutique placée dans ou sur le matériau support de libération prolongée. La composition active au niveau pharmaceutique comprend au moins un constituant actif au niveau pharmaceutique et un support pour celui-ci. Chaque implant possède une taille et/ou une charge utile individuelles insuffisantes pour obtenir une concentration sanguine seuil voulue prédéterminée d' un agent pharmaceutique actif dans le traitement d'une indication choisie.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)